{"id":"two-policies-of-iron-prophylaxis","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal upset (nausea, constipation, abdominal discomfort)"},{"rate":null,"effect":"Dark stools"},{"rate":null,"effect":"Metallic taste"}]},"_chembl":{"chemblId":"CHEMBL1200823","moleculeType":"Small molecule","molecularWeight":"398.14"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iron prophylaxis involves the administration of iron supplements (typically ferrous salts or iron compounds) to individuals at high risk of iron deficiency, such as pregnant women, infants, or those with chronic blood loss. These policies aim to maintain adequate iron stores and hemoglobin levels, preventing the development of iron deficiency anemia and its associated complications including impaired cognitive development, reduced work capacity, and increased infection risk.","oneSentence":"Iron prophylaxis policies provide supplemental iron to prevent iron deficiency anemia in at-risk populations.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:39:20.142Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency prevention in pregnant women"},{"name":"Iron deficiency prevention in infants and young children"},{"name":"Iron deficiency prevention in populations at risk of anemia"}]},"trialDetails":[{"nctId":"NCT00488579","phase":"PHASE4","title":"Routine Iron Prophylaxis During Pregnancy","status":"COMPLETED","sponsor":"National Istitute For Health and Welfare, Finland","startDate":"2007-05","conditions":"Pregnancy","enrollment":4326}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Two policies of iron prophylaxis","genericName":"Two policies of iron prophylaxis","companyName":"National Istitute For Health and Welfare, Finland","companyId":"national-istitute-for-health-and-welfare-finland","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron prophylaxis policies provide supplemental iron to prevent iron deficiency anemia in at-risk populations. Used for Iron deficiency prevention in pregnant women, Iron deficiency prevention in infants and young children, Iron deficiency prevention in populations at risk of anemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}